Compounded
Compounded Tirzepatide
Dual-action GIP + GLP-1 injection — compounded by a licensed U.S. pharmacy.
- Same active ingredient (tirzepatide) as brand-name GIP + GLP-1 medications
- Once-weekly subcutaneous injection
- Dual-action: activates GIP and GLP-1 receptors
- Tirzepatide is a dual GIP and GLP-1 receptor agonist — activating two hormone pathways involved in appetite and blood sugar regulation.
- Compounded tirzepatide is prepared by a licensed U.S. compounding pharmacy — it is not FDA-approved. It is dispensed only when a licensed provider determines it is clinically appropriate.
- Once-weekly subcutaneous injection, self-administered at home.
- Dosing starts low and is gradually titrated up based on your response and tolerance.
- Supports appetite regulation, cravings, and glycemic control alongside lifestyle changes.
- Your care team helps you manage side effects and fine-tune the plan over time.
Two hormone pathways. One weekly shot.
Get started todayDual-action mechanism — the same active ingredient class as brand-name tirzepatide medications.
*Compounded medications are not FDA-approved. Individual results vary.
See your potential
How much could you lose?
Current weight
252lbs
You could lose
38lbs
Based on clinical GLP-1 trial averages. Individual results vary.
How it works
The science, simplified.
Tirzepatide works on two hormone pathways at once (GIP and GLP-1), amplifying appetite suppression and metabolic improvements compared to single-pathway medications. Starting at as low as $249/mo with a 12-month plan — compounded medication and care included.
Disclaimer: Dosage, treatment plan, and pricing will vary based on your individual health profile and the recommendations of your licensed provider. Final pricing and protocol are determined after clinical review. This page is for informational purposes only and is not a substitute for medical advice. See Important Safety Information.